KemPharm, Inc.
(NASDAQ : KMPH)

( )
KMPH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.27%169.660.4%$320.20m
AMRNAmarin Corporation Plc Sponsored ADR
-0.66%16.572.0%$230.48m
JAZZJazz Pharmaceuticals Plc
0.52%140.382.2%$115.52m
PRGOPerrigo Co. Plc
-0.59%58.506.8%$76.50m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.17%122.996.3%$56.21m
MNKMallinckrodt Plc
1.31%20.9521.1%$55.98m
ICLRICON Plc
-0.60%138.224.1%$45.41m
SAGESAGE Therapeutics, Inc.
0.27%107.849.6%$42.66m
UTHRUnited Therapeutics Corporation
1.19%109.7914.4%$41.16m
ENDPEndo International Plc
-1.23%11.218.9%$39.61m
ICPTIntercept Pharmaceuticals, Inc.
-1.32%104.5918.6%$39.16m
HZNPHorizon Pharma plc
0.00%19.567.4%$37.50m
CTLTCatalent Inc
1.67%36.302.4%$36.50m
PTLAPortola Pharmaceuticals, Inc.
-6.65%19.507.7%$26.63m
ZGNXZogenix, Inc.
1.32%43.6510.0%$26.00m

Company Profile

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA.